RxDoctor Payments Data

Tara Goosey

Nurse Practitioner · Archie, MONPI 1225743271

Payments from drug & device makers

$4,947in general payments, 2019–2025

Across 140 payments — averaging $35.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$582
  • Bayer$498
  • Otsuka America Pharmaceutical, Inc.$334
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$292
  • Teva Pharmaceuticals USA, Inc.$269
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,947 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol55$55,124
OzempicSemaglutide20$20,062
GemtesaVibegron14$16,555
Janumet XrSitagliptin Phos/Metformin Hcl11$6,199
Gabapentin60$904
Atorvastatin Calcium122$625
Rosuvastatin Calcium61$420
Losartan Potassium55$397
Lisinopril87$395
Levothyroxine Sodium63$383
Amlodipine Besylate78$299
Valsartan33$281
Albuterol Sulfate HfaAlbuterol Sulfate17$273
Tizanidine Hcl29$268
Omeprazole27$258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$1,877$55,12455 claims
Novo NordiskOzempic$86$20,06220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Archie

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →